Long‐term results of weekly/daily cisplatin‐based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|21|3769-3775

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.21, 2013-11, pp. : 3769-3775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized phase III study of 2 cisplatin‐based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 11, 2015-11 ,pp. : 1583-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation

By  

Oncology, Vol. 89, Iss. 4, 2015-06 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta‐analysis

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 1073-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 290-296

Karger

Access to resources Recommend Favorite